We are live on ! Find out more
RCEL icon

Avita Medical
RCEL

Fund managers haven’t disclosed any holdings of RCEL yet.

RCEL Hedge Fund Activity: Q1 2026 in Review

79 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2026, worth a combined $61.9M — up 272% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCEL positions and 13 closed out — a net gain of 13 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $2.29M. The largest seller was Bridgeway Capital Management, cutting an estimated $368K.

  • 79 institutional investors held Avita Medical (RCEL) as of Q1 2026, up from 67 in Q4 2025.
  • Funds reported $61.9M of Avita Medical stock for Q1 2026, up 272% quarter-over-quarter.
  • 26 funds opened new Avita Medical positions in Q1 2026 and 13 closed out, a net change of +13 holders.
  • The largest Avita Medical buyer in Q1 2026 was OrbiMed, an estimated $2.29M added.
  • The largest Avita Medical seller in Q1 2026 was Bridgeway Capital Management, an estimated $368K sold.

Based on aggregated 13F filings for Q1 2026.